Determining the in-hospital cost of bleeding in patients undergoing percutaneous coronary intervention

Journal of Interventional Cardiology

Volumn 22, Issue 3, 2009, Pages 266-273

  Ewen, Edward F ^a   Zhao, Liping ^a   Kolm, Paul ^a   Jurkovitz, Claudine ^a   Fidan, Dogan ^b   White, Harvey D ^c   Gallo, Richard ^d   Weintraub, William S ^a  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

^b SANOFI   (France)

^c GREEN LANE HOSPITAL   (New Zealand)

^d MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; COST OF ILLNESS; FEMALE; HOSPITAL CHARGE; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; ECONOMICS; HEALTH ECONOMICS; HEMORRHAGE; LENGTH OF STAY; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONFIDENCE INTERVALS; ECONOMICS, HOSPITAL; FEMALE; HEMORRHAGE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; ANGIOPLASTY, BALLOON, CORONARY;

EID: 66749154223     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2009.00431.x     Document Type: Article

References (20)

1. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics-2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007 115 : e69 e171.
2. Lauer MA, Karweit JA, Cascade EF, et al. Practice patterns and outcomes of percutaneous coronary interventions in the United States: 1995 to 1997. Am J Cardiol 2002 89 : 924 929. (Pubitemid 34310288)
3. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003 349 : 1315 1323. (Pubitemid 37186209)
4. Weintraub WS, Mahoney EM, Ghazzal ZM, et al. Trends in outcome and costs of coronary intervention in the 1990s. Am J Cardiol 2001 88 : 497 503. (Pubitemid 32778494)
5. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med 1993 329 : 673 682.
6. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review. JAMA 1997 278 : 2093 2098. (Pubitemid 28016233)
7. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001 345 : 494 502. (Pubitemid 32758501)
8. Rao SV. Implications of bleeding and blood transfusion in percutaneous coronary intervention. Rev Cardiovasc Med 2007 8 (Suppl 3 S18 S26.
9. Milkovich G, Gibson G. Economic impact of bleeding complications and the role of antithrombotic therapies in percutaneous coronary intervention. Am J Health Syst Pharm 2003 60 (14 Suppl 3 S15 S21.
10. Rao SV, Eikelboom JA, Granger CB, et al. Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007 28 : 1193 1204. (Pubitemid 47343833)
11. Rao SV, Kaul PR, Liao L, et al. Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. Am Heart J 2008 155 : 369 374.
12. Weintraub WS, ed. Cardiovascular Health Care Economics. Totowa, NJ : Humana Press, 2003, pp. 1 30.
13. Rao AK, Pratt C, Berke A, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial-phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 1988 11 : 1 11. (Pubitemid 18029027)
14. Montalescot G, White HD, Gallo R, et al. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention see comment. N Engl J Med 2006 355 : 1006 1017. (Pubitemid 44343544)
15. Yusuf S, Mehta SR, Chrolavicius S, et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006 354 : 1464 1476.
16. Yusuf S, Mehta SR, Chrolavicius S, et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: The OASIS-6 randomized trial. JAMA 2006 295 : 1519 1530.
17. Stone GW, Bertrand M, Colombo A, et al. Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: Study design and rationale. Am Heart J 2004 148 : 764 775.
18. Producer Price Index for General Medical and Surgical Hospitals, 1992-2005. Vol. 2006: US Department of Labor, Bureau of Labor Statistics accessed November 1, 2006. Available at http://www.bls.gov/ppi/home.htm2006.
19. Weintraub W, Jonsson B, Bertrand M. The value of clopidogrel in addition to standard therapy in reducing atherothrombotic events. Pharmacoeconomics 2004 22 (Suppl 4 29 41. (Pubitemid 40066091)
20. Cohen DJ, Lincoff AM, Lavelle TA, et al. Economic evaluation of bivalirudin with provisional glycoprotein IIB-IIIA inhibition versus heparin with routine glycoprotein IIB-IIIA inhibition for percutaneous coronary intervention: Results from the REPLACE-2 trial. J Am Coll Cardiol 2004 44 : 1792 1800. (Pubitemid 39424077)